Can be recommended as an additional source of biologically active plant substances that promotes to carbohydrate metabolism and blood glucose normalization.
Show instructions for useClose
Instruction for use
Composition (1 capsule): Gymnema sylvestre leaf extract — 100 mg, Momordica charantia fruit extract — 100 mg, Azadirachta indica leaf extract — 80 mg, Asphaltum exudate — 40 mg, Picrorhiza kurroa rhizome extract — 30 mg, Ocimum sanctum leaf extract — 15 mg, Zingiber officinale rhizome — 40 mg, Commiphora mukul exudate — 50 mg, Syzygium cumini seed extract — 50 mg.
Excipients: Sodium Benzoate.
Recommendations for use: can be recommended as an additional source of biologically active plant substances that promotes to carbohydrate metabolism and blood glucose normalization.
It is recommended to follow a balanced diet with restriction of animal fats, sweets and alcohol.
It is recommended to consult a physician before use.
Method of administration: for adults 1 capsule twice daily before meals, rinse with water.
Term of use: 60 days, than period of administration and the possibility of repeated courses should be confirmed by the doctor.
Caloric value (Energy value) 100 g of product: 138.15 kcal (577.46 kJ).
Feed value (Nutritional value) of 100 g of product: protein – 6.57 g, fat – 6.57 g, carbohydrate – 13.15 g.
Precautions at use: individual hypersensitivity to any component, children, pregnancy and breastfeeding.
Release form: capsules No.30, 60, 100, 120 and 200.
Shelf life: 3 years from the manufacturing date.
Storage conditions: store in dry protected from light places at temperature not exceeding 30˚C. Keep out of reach of children.
Food supplement. Is not a medicine. Does not contain GMO.
Manufacturer: «Ananta Medicare Limited», legal address: 621, Ring Road Mall, Sector-3, Rohini, New Delhi-110085, India; manufacturing site address: G-1-265, Phase-II, RIICO Industrial Area, Udyog Vihar, Sri Ganganagar (Raj.), India.
Importer: LLC «Evitas», 61001, Ukraine, Kharkiv, Iskrinska str., 37.
Conclusion of sanitary-epidemiological expertise № 05.03.02.-03/20583 dated 15.05.2015